Long-Term Outcomes of Resynchronization-Defibrillation for Heart Failure.
Sapp JL, Sivakumaran S, Redpath CJ, Khan H, Parkash R, Exner DV, Healey JS, Thibault B, Sterns LD, Lam NHN, Manlucu J, Mokhtar A, Sumner G, McKinlay S, Kimber S, Mondesert B, Talajic M, Rouleau J, McCarron CE, Wells G, Tang ASL; RAFT Long-Term Study Team.
N Engl J Med. 2024 Jan 18;390(3):212-220. doi: 10.1056/NEJMoa2304542.
Upgrade of right ventricular pacing to cardiac resynchronization therapy in heart failure: a randomized trial.
Merkely B, Hatala R, Wranicz JK, Duray G, Földesi C, Som Z, Németh M, Goscinska-Bis K, Gellér L, Zima E, Osztheimer I, Molnár L, Karády J, Hindricks G, Goldenberg I, Klein H, Szigeti M, Solomon SD, Kutyifa V, Kovács A, Kosztin A.
Eur Heart J. 2023 Oct 21;44(40):4259-4269. doi: 10.1093/eurheartj/ehad591.
Cardiac resynchronization therapy with or without defibrillator in patients with heart failure.
Schrage B, Lund LH, Melin M, Benson L, Uijl A, Dahlström U, Braunschweig F, Linde C, Savarese G.
Europace. 2022 Jan 4;24(1):48-57. doi: 10.1093/europace/euab233.
Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project.
Hadwiger M, Dagres N, Haug J, Wolf M, Marschall U, Tijssen J, Katalinic A, Frielitz FS, Hindricks G.
Eur Heart J. 2022 Jul 14;43(27):2591-2599. doi: 10.1093/eurheartj/ehac053.
Follow-up and characteristics of recipients of cardiac resynchronization therapy with and without a defibrillator.
Grymuza M, Katarzyńska-Szymańska A, Chmielewska-Michalak L, Waśniewski M, Ochotny R, Lesiak M, Mitkowski P.
Kardiol Pol. 2022;80(7-8):806-812. doi: 10.33963/KP.a2022.0125. Epub 2022 May 12.
Cardiac Resynchronization Therapy With or Without Defibrillation: A Long-Standing Debate.
Golzio PG, Bocchino PP, Bissolino A, Angelini F, Gravinese C, Frea S.
Cardiol Rev. 2022 Sep-Oct 01;30(5):221-233. doi: 10.1097/CRD.0000000000000388. Epub 2021 Mar 19.
Use of Cardiac Resynchronization Therapy Defibrillator in US Hospitals.
Sandhu A, Bao H, Minges KE, Varosy PD, Borne RT, Zipse MM, Marzec L, Peterson P, Masoudi F, Bradley SM.
JAMA Cardiol. 2019 Aug 1;4(8):804-809. doi: 10.1001/jamacardio.2019.1755.
Cardiac Resynchronization Therapy with Defibrillator in Ischemic Versus Nonischemic Cardiomyopathy.
Yuecel G, Gaasch L, Hetjens S, Oeztuerk ON, Yildirim G, Pfleger S, Duerschmied D, Akin I, Kuschyk J.
Int Heart J. 2024;65(5):823-832. doi: 10.1536/ihj.24-023.
Effectiveness of adding a defibrillator with cardiac resynchronization therapy in heart failure according to the modified Model for End-stage Liver Disease-Albumin score.
Cheng S, Deng Y, Huang H, Yu Y, Niu H, Hua W.
Europace. 2023 Aug 2;25(9):euad232. doi: 10.1093/europace/euad232.
Variation in hospital use of cardiac resynchronization therapy-defibrillator among eligible patients and association with clinical outcomes.
Chui PW, Lan Z, Freeman JV, Enriquez AD, Khera R, Akar JG, Masoudi FA, Ong EL, Curtis JP.
Heart Rhythm. 2023 Jul;20(7):1000-1008. doi: 10.1016/j.hrthm.2023.03.022. Epub 2023 Mar 22.
